Showing results (3161-3170 of 8,098) with videos related to
Sort By:
Pageof 810
Current Medicinal Chemistry|April 10, 2009
Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegenerationZhiying Hu, Yan Li, Marong Fang, et al.Current Medicinal Chemistry|April 10, 2009
Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseasesSmita Jagtap, Kesavan Meganathan, Vilas Wagh, et al.Current Medicinal Chemistry|April 10, 2009
Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overviewL M Riou, A Broisat, J Dimastromatteo, et al.Current Medicinal Chemistry|December 17, 2008
New inhibitors of glycogen phosphorylase as potential antidiabetic agentsL Somsák, K Czifrák, M Tóth, et al.Current Medicinal Chemistry|December 17, 2008
Targeting vascular niche by parathyroid hormoneCaterina Pagliarulo, Paola Salvatore, Claudio NapoliCurrent Medicinal Chemistry|December 17, 2008
Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measuresF De Lorenzo, S Collot-Teixeira, M Boffito, et al.Current Medicinal Chemistry|December 17, 2008
Cancer stem cells: how can we target them?Ivan Ischenko, Hendrik Seeliger, Moshe Schaffer, et al.Current Medicinal Chemistry|December 17, 2008
Copper transport systems are involved in multidrug resistance and drug transportTatsuhiko Furukawa, Masaharu Komatsu, Ryuji Ikeda, et al.Current Medicinal Chemistry|September 28, 2007
CD4+CD25+ T regulatory cells and TGF-beta in mucosal immune system: the good and the badWanjun Chen, Sylvain Perruche, Jun LiCurrent Medicinal Chemistry|September 28, 2007
Small molecule CXCR4 chemokine receptor antagonists: developing drug candidatesAbid Khan, John Greenman, Stephen J ArchibaldPageof 810